John Poduska - Rewalk Robotics Independent Director Nominee
| RWLKDelisted Stock | USD 1.05 0.04 3.96% |
Director
Dr. John William Poduska, Sr., Ph.D., serves as an Independent Director of ReWalk Robotics Ltd. He has served on our Board since 2014 as an external director under the Israeli Companies Law. Dr. Poduska currently serves as a director of EXA Corporation, a developer and provider of simulation software systems, where he serves as chairman of the compensation committee and a member of the nominating and governance committee. He also serves as a director on the boards of a number of privatelyheld companies. Dr. Poduska also served as a director of Novell, Inc. until 2011 and of Anadarko Petroleum Corporation and Safeguard Scientifics, Inc. until 2009. Dr. Poduska was the Chairman of Advanced Visual Systems Inc., a provider of visualization software, from January 1992 to December 2001. From December 1989 until December 1991, Dr. Poduska was President and Chief Executive Officer of Stardent Computer Inc., a computer manufacturer. From December 1985 until December 1989, Dr. Poduska served as Chairman and Chief Executive Officer of Stellar Computer Inc., a computer manufacturer he founded which is the predecessor of Stardent Computer Inc. Prior to founding Stellar Computer, Inc., Dr. Poduska founded Apollo Computer Inc. and Prime Computer, Inc since 2014.
| Age | 77 |
| Tenure | 10 years |
| Professional Marks | Ph.D |
| Phone | 972 4 959 0123 |
| Web | https://www.rewalk.com |
Rewalk Robotics Management Efficiency
The company has return on total asset (ROA) of (0.1665) % which means that it has lost $0.1665 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3424) %, meaning that it created substantial loss on money invested by shareholders. Rewalk Robotics' management efficiency ratios could be used to measure how well Rewalk Robotics manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 897 K in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Rewalk Robotics has a current ratio of 21.61, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Rewalk Robotics until it has trouble settling it off, either with new capital or with free cash flow. So, Rewalk Robotics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Rewalk Robotics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Rewalk to invest in growth at high rates of return. When we think about Rewalk Robotics' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Harold Jacob | NanoVibronix | 59 | |
| James Coyne | STRATA Skin Sciences | N/A | |
| Samuel Navarro | STRATA Skin Sciences | ||
| Lisa Heine | SurModics | 54 | |
| Susan Knight | SurModics | 63 | |
| Shawn McCormick | SurModics | 53 | |
| John Booth | Bone Biologics Corp | 60 | |
| Giora Yanay | BrainsWay | 74 | |
| Abraham Zangen | BrainsWay | N/A | |
| Eynat Tsafrir | BrainsWay | 51 | |
| Karen Sarid | BrainsWay | 66 | |
| Yosef Shalom | BrainsWay | 61 | |
| Kathryn Swintek | STRATA Skin Sciences | 62 | |
| Michael Ferguson | NanoVibronix | 42 | |
| Yaacov Michlin | BrainsWay | 48 | |
| David Dantzker | SurModics | 74 | |
| Rox Anderson | STRATA Skin Sciences | N/A | |
| Yiftach Roth | BrainsWay | 52 | |
| Orly Uri | BrainsWay | 59 | |
| John Benson | SurModics | 69 | |
| Bret Hankey | Bone Biologics Corp | 39 | |
Management Performance
| Return On Equity | -0.34 | |||
| Return On Asset | -0.17 |
Rewalk Robotics Leadership Team
Elected by the shareholders, the Rewalk Robotics' board of directors comprises two types of representatives: Rewalk Robotics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Rewalk. The board's role is to monitor Rewalk Robotics' management team and ensure that shareholders' interests are well served. Rewalk Robotics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Rewalk Robotics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| MBA BS, CEO Director | ||
| Jeff Dykan, Independent Chairman of the Board | ||
| Jay Kalish, Independent Director | ||
| John Hamilton, Vice President - Regulatory and Clinical | ||
| Miri Pariente, Global Director - Quality | ||
| Yohanan Engelhardt, Director | ||
| Charles Remsberg, Chief Officer | ||
| Glenn Muir, Independent Director | ||
| Wayne Weisman, Independent Director | ||
| Kevin Hershberger, CFO | ||
| Michael Lawless, Chief Officer | ||
| Deborah DiSanzo, Director | ||
| Lawrence Jasinski, CEO, Director | ||
| Ofir Koren, VP of RandD | ||
| Ning Cong, Independent Director | ||
| Ami Kraft, Ex CEO | ||
| Asaf Shinar, Independent Director | ||
| Judy Kula, Human Service | ||
| John Poduska, Independent Director Nominee | ||
| Ori Gon, CFO | ||
| Ori Schellas, Director of Operations | ||
| Aryeh Dan, Director | ||
| David Hexner, VP RD | ||
| Chunlin Han, Director | ||
| Kathleen ODonnell, Vice Development | ||
| Larry Jasinski, CEO, Director | ||
| Jodi Gricci, VP of Global Marketing | ||
| Hadar Ron, Independent Director | ||
| Peter Wehrly, Independent Director | ||
| Yasushi Ichiki, Director | ||
| Jeannine Lynch, Vice Strategy |
Rewalk Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Rewalk Robotics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.34 | |||
| Return On Asset | -0.17 | |||
| Profit Margin | (2.38) % | |||
| Operating Margin | (1.24) % | |||
| Current Valuation | 28.94 M | |||
| Shares Outstanding | 60.02 M | |||
| Shares Owned By Insiders | 1.96 % | |||
| Shares Owned By Institutions | 20.71 % | |||
| Number Of Shares Shorted | 1.36 M | |||
| Price To Earning | (0.77) X |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Rewalk Stock
If you are still planning to invest in Rewalk Robotics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rewalk Robotics' history and understand the potential risks before investing.
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |